| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amicus Therapeutics, Inc. (FOLD) has 6 insiders with recent SEC Form 4 filings, including 3 buys and 7 sells. FOLD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.02M | $14.80M | - | |
| Other | 464.6K | $6.73M | - | |
| Other | 409.3K | $5.93M | - | |
| Other | 221.8K | $3.21M | - | |
| CFO | 143.6K | $2.08M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2018 | Perceptive Advisors LLC51 | 10% Owner | Buy | 50,000 | $12.53 | $626,500.00 | +0.2% | |
| Sep 13, 2018 | Perceptive Advisors LLC51 | 10% Owner | Buy | 100,000 | $11.74 | $1,174,000.00 | +0.5% | |
| Sep 12, 2018 | Perceptive Advisors LLC51 | 10% Owner | Buy | 500,000 | $12.00 | $6,001,500.00 | +2.5% | |
| Jul 2, 2018 | Baird William D III | Chief Financial Officer | Sale+OE | 10,000 | $15.63 | $156,292.00 | -8.5% | |
| Jul 2, 2018 | Andrews Kurt J. | SVP, Human Resources | Sale+OE | 5,000 | $15.63 | $78,165.50 | -12.4% | |
| Jun 1, 2018 | Do Hung | Chief Science Officer | Sell | 25,000 | $16.72 | $418,000.00 | -5.9% | |
| May 16, 2018 | McGlynn Margaret G51 | Director | Sale+OE | 10,000 | $16.00 | $160,000.00 | -38.7% | |
| May 16, 2018 | Do Hung | Chief Science Officer | Sell | 25,000 | $15.00 | $375,000.00 | -5.6% | |
| May 14, 2018 | Barth Jay | Chief Medical Officer | Sale+OE | 5,000 | $14.04 | $70,222.50 | -5.5% | |
| Apr 17, 2018 | Do Hung | Chief Science Officer | Sell | 50,000 | $15.00 | $750,000.00 | -10.1% |